Filing Details

Accession Number:
0001104659-13-052054
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-06-27 21:34:18
Reporting Period:
2013-05-15
Filing Date:
2013-06-27
Accepted Time:
2013-06-27 21:34:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1070081 Ptc Therapeutics Inc. PTCT Pharmaceutical Preparations (2834) 043416587
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1550424 Mark Rothera C/O Ptc Therapeutics, Inc.
100 Corporate Court
South Plainfield NJ 07080
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-06-25 25,000 $15.00 25,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2013-05-15 15,000 $10.85 15,000 $10.85
Common Stock Stock Option (right to buy) Acquisiton 2013-05-15 150,000 $10.85 150,000 $10.85
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
15,000 2023-05-15 No 4 P Direct
165,000 2023-05-15 No 4 P Direct
Footnotes
  1. This option was granted on May 15, 2013 and vests over four years, subject to achievement of specified performance objectives, with 25% of the shares underlying the option vesting on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on January 31, 2014.
  2. This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vesting on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 30, 2014.